Embelin mitigates hepatotoxicity induced by isoniazid and rifampicin in rats

Isoniazid and rifampicin are reliable drugs against tuberculosis, but while effective, their use is associated with the risk of drug-induced liver damage. Embelin, a natural parabenzoquinone derived from the Embelia ribes plant, has gained attention for its potential therapeutic properties, anti...

Full description

Saved in:
Bibliographic Details
Main Author: O. F. Mosa
Format: Article
Language:English
Published: National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry 2024-06-01
Series:The Ukrainian Biochemical Journal
Subjects:
Online Access:http://ukrbiochemjournal.org/wp-content/uploads/2024/06/Mosa_96_3.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850026404000825344
author O. F. Mosa
author_facet O. F. Mosa
author_sort O. F. Mosa
collection DOAJ
description Isoniazid and rifampicin are reliable drugs against tuberculosis, but while effective, their use is associated with the risk of drug-induced liver damage. Embelin, a natural parabenzoquinone derived from the Embelia ribes plant, has gained attention for its potential therapeutic properties, antioxidant and organ-protective effects. The study aimed to assess the hepatoprotective properties of embelin against liver dama­ge induced by isoniazid and rifampicin in rats. Wistar rats were used, and liver damage was induced by administration of isoniazid (100 mg/kg) and rifampicin (100 mg/kg). Embelin was given at doses of 50, 75, and 100 mg/kg for 21 days. All the drugs were given orally. Serum levels of the oxidative stress markers, aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP) activity measured by enzymatic assay kits (Elabscience, China), and the levels of tumour necrosis factor-α (TNF-α), interleukins IL-1β and IL-6 measured by ELISA kits (Randox, UK) were estimated. Embelin administration at varying doses effectively restored AST, ALT, ALP, SOD and catalase activity and notably decreased MDA and nitric oxide concentration as well as expression of inflammatory cytokines TNF-α, IL-1β and IL-6 in the serum of animals with drug-induced liver damage. These findings underscore embelin’s hepatoprotective effects, likely attributed to its radical scavenging properties and ability to suppress cytokine production.
format Article
id doaj-art-898b8f3dba744570a5a09eaa4a8db59e
institution DOAJ
issn 2409-4943
2413-5003
language English
publishDate 2024-06-01
publisher National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry
record_format Article
series The Ukrainian Biochemical Journal
spelling doaj-art-898b8f3dba744570a5a09eaa4a8db59e2025-08-20T03:00:34ZengNational Academy of Sciences of Ukraine, Palladin Institute of BiochemistryThe Ukrainian Biochemical Journal2409-49432413-50032024-06-01963485610.15407/ubj96.03.048Embelin mitigates hepatotoxicity induced by isoniazid and rifampicin in ratsO. F. Mosa0https://orcid.org/0000-0001-5052-7116Public Health Department, College of Al-Lieth Health Science, Umm Al Qura University, Makkah, Saudi Arabia Isoniazid and rifampicin are reliable drugs against tuberculosis, but while effective, their use is associated with the risk of drug-induced liver damage. Embelin, a natural parabenzoquinone derived from the Embelia ribes plant, has gained attention for its potential therapeutic properties, antioxidant and organ-protective effects. The study aimed to assess the hepatoprotective properties of embelin against liver dama­ge induced by isoniazid and rifampicin in rats. Wistar rats were used, and liver damage was induced by administration of isoniazid (100 mg/kg) and rifampicin (100 mg/kg). Embelin was given at doses of 50, 75, and 100 mg/kg for 21 days. All the drugs were given orally. Serum levels of the oxidative stress markers, aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP) activity measured by enzymatic assay kits (Elabscience, China), and the levels of tumour necrosis factor-α (TNF-α), interleukins IL-1β and IL-6 measured by ELISA kits (Randox, UK) were estimated. Embelin administration at varying doses effectively restored AST, ALT, ALP, SOD and catalase activity and notably decreased MDA and nitric oxide concentration as well as expression of inflammatory cytokines TNF-α, IL-1β and IL-6 in the serum of animals with drug-induced liver damage. These findings underscore embelin’s hepatoprotective effects, likely attributed to its radical scavenging properties and ability to suppress cytokine production.http://ukrbiochemjournal.org/wp-content/uploads/2024/06/Mosa_96_3.pdfantioxidant effectcytokine suppressionembelinhepatoprotectionisoniazidrifampicin
spellingShingle O. F. Mosa
Embelin mitigates hepatotoxicity induced by isoniazid and rifampicin in rats
The Ukrainian Biochemical Journal
antioxidant effect
cytokine suppression
embelin
hepatoprotection
isoniazid
rifampicin
title Embelin mitigates hepatotoxicity induced by isoniazid and rifampicin in rats
title_full Embelin mitigates hepatotoxicity induced by isoniazid and rifampicin in rats
title_fullStr Embelin mitigates hepatotoxicity induced by isoniazid and rifampicin in rats
title_full_unstemmed Embelin mitigates hepatotoxicity induced by isoniazid and rifampicin in rats
title_short Embelin mitigates hepatotoxicity induced by isoniazid and rifampicin in rats
title_sort embelin mitigates hepatotoxicity induced by isoniazid and rifampicin in rats
topic antioxidant effect
cytokine suppression
embelin
hepatoprotection
isoniazid
rifampicin
url http://ukrbiochemjournal.org/wp-content/uploads/2024/06/Mosa_96_3.pdf
work_keys_str_mv AT ofmosa embelinmitigateshepatotoxicityinducedbyisoniazidandrifampicininrats